Accepted for/Published in: JMIR Research Protocols
Date Submitted: Aug 16, 2024
Open Peer Review Period: Aug 30, 2024 - Sep 15, 2024
Date Accepted: Sep 28, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The INtegrating CuLtUral aspects into Diabetes Education (INCLUDE) study: protocol for a multi-level, mHealth-based intervention to prevent diabetes in Chinese immigrants
ABSTRACT
Background:
Type 2 diabetes (T2D) contributes to significant morbidity and mortality for Chinese immigrants in the United States, exacerbated by social determinants of health (SDOH) barriers such as language barriers, limited access to healthy foods, and low health literacy.
Objective:
The goal of the INtegrating CuLtUral aspects into Diabetes Education (INCLUDE) study is to test a social media-based intervention adapting the Diabetes Prevention Program (DPP) for Chinese immigrants alongside a culturally adapted community-supported agriculture (CSA) program. We report the protocol for the INCLUDE study.
Methods:
INCLUDE is a three-year randomized controlled trial (n=150). Participants with prediabetes or at risk for T2D are enrolled and randomized into either the control or intervention group (n=75 each). Participants from the intervention group receive 2-3 culturally tailored, in-language DPP videos weekly for 12 weeks, and biweekly phone calls from bilingual study staff to review video content, support goal setting, and assess and address SDOH-related barriers such as food insecurity. Intervention participants will also be given produce for 10 weeks as part of the CSA program. Weight (primary outcome), self-efficacy, diet, physical activity, and food insecurity (secondary outcomes) are measured at baseline, 3-month, and 6-month intervals. Splined linear mixed models will be used to examine group differences in longitudinal weight and other secondary outcomes. The INCLUDE study was approved by the Institutional Review Board at the NYU Grossman School of Medicine.
Results:
Recruitment started in May 2023, with the first cohort of 75 participants enrolled and randomized into two groups in July 2023. The 3-month and 6-month assessment of the first year’s cohort has been completed. We have recruited 75 participants for the second cohort by July 2024.
Conclusions:
The INCLUDE study will serve as an innovative model for culturally adapted multi-level interventions for underserved communities previously unable to access evidence-based diabetes prevention initiatives. Aligning with several national calls for multi-level interventions, the INCLUDE intervention will provide critical data that will inform how researchers and public health professionals address SDOH barriers faced by underserved populations and prevent diabetes. Clinical Trial: This study was registered at ClinicalTrials.gov, NCT05492916. Registered 08/09/2022, https://clinicaltrials.gov/study/NCT05492916.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.